Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours

scientific article published on 21 October 2016

Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/CEN.13264
P698PubMed publication ID27770475

P2093author name stringW F Young
G B Thompson
Z Al-Hilli
B L Clarke
R Rodriguez-Gutierrez
D Donegan
N Singh Ospina
P2860cites workInherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesQ24647838
Positional cloning of the gene for multiple endocrine neoplasia-type 1Q28307577
Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreasQ31030383
Are patients with multiple endocrine neoplasia type I prone to premature death?Q34064454
Genetic aspects of adenomatosis of endocrine glandsQ34234754
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).Q34283436
Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice GuidelineQ34905558
Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumorsQ35197186
Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experienceQ35987844
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumorsQ37056120
Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostainingQ37302846
Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.Q38157760
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study GroupQ40123801
Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patientsQ44301609
Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndromeQ46191004
A follow-up study of patients with Zollinger-Ellison syndrome in the period 1966-2002: effects of surgical and medical treatments on long-term survivalQ46426134
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinomaQ48100816
Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.Q53312970
Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.Q54323177
KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers.Q54474847
P433issue2
P921main subjectmultiple endocrine neoplasiaQ1553018
multiple endocrine neoplasia type 1Q3347154
P304page(s)199-206
P577publication date2016-10-21
P1433published inClinical EndocrinologyQ15762781
P1476titleLong-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours
P478volume86

Reverse relations

cites work (P2860)
Q48120158Heritable forms of primary hyperparathyroidism: a current perspective.
Q91787051Multiple Endocrine Neoplasia Type 1: A Case Report With Review of Imaging Findings
Q54638848Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.

Search more.